CT News and Research RSS Feed - CT News and Research

Intra-arterial stroke treatment more effective than medical management with tPA, study finds

Intra-arterial stroke treatment more effective than medical management with tPA, study finds

Penumbra, Inc., the market leader in intra-arterial stroke treatment, announced that an independent study published online today in the New England Journal of Medicine found that intra-arterial stroke treatment, including the company's clot extraction technology, was shown to be significantly more effective than medical management with tissue plasminogen activator (tPA), which is the current standard of care. [More]
Researchers find new 'sliding scale' model to rule out blood clots in lungs

Researchers find new 'sliding scale' model to rule out blood clots in lungs

Researchers from Intermountain Medical Center in Salt Lake City have identified a new "sliding scale" model used to rule out potentially deadly blood clots in the lungs, known as pulmonary embolisms, that is more accurate than current diagnostic methods. [More]
Apheresis: A potent therapeutic in extracorporeal photopherisis

Apheresis: A potent therapeutic in extracorporeal photopherisis

Apheresis, the simple process of drawing blood, becomes a powerful therapeutic in extracorporeal photopherisis (ECP) according to clinicians and scientists who met at the NIH State of the Science Symposium in Therapeutic Apheresis. Nora Ratcliffe, MD, of Dartmouth Hitchcock, looked at current methodology and opportunities for research in a paper recently published in Transfusion Medicine Review, titled "National Institutes of Health State of the Science Symposium in Therapeutic Apheresis: Scientific Opportunities in Extracorporeal Photopheresis." [More]
Midazolam drug helps recover full consciousness in traumatic brain injury patient

Midazolam drug helps recover full consciousness in traumatic brain injury patient

A patient who had suffered a traumatic brain injury unexpectedly recovered full consciousness after the administration of midazolam, a mild depressant drug of the GABA A agonists family. [More]
New study compares usefulness of two biomarkers released into the blood after TBI

New study compares usefulness of two biomarkers released into the blood after TBI

In cases of traumatic brain injury (TBI), predicting the likelihood of a cranial lesion and determining the need for head computed tomography (CT) can be aided by measuring markers of bone injury in the blood. [More]
Using refractory metals in cancer treatments: an interview with Robert Desberg, H.C. Starck

Using refractory metals in cancer treatments: an interview with Robert Desberg, H.C. Starck

By developing and producing customized powder morphologies and high-precision mill products, and fabricated and machined components from the refractory metals tungsten, molybdenum, tantalum, and niobium, H.C. Starck makes a significant contribution to enabling cutting-edge developments in innovative high-tech industries. [More]
New technique shows promise for early diagnosis of cardiovascular disease

New technique shows promise for early diagnosis of cardiovascular disease

A new technique developed at Sweden's KTH Royal Institute of Technology shows promise for early diagnosis and treatment of cardiovascular disease. [More]
MorphoSys, Xencor announce final results from MOR208 Phase 1/2a trial in patients with CLL/SLL

MorphoSys, Xencor announce final results from MOR208 Phase 1/2a trial in patients with CLL/SLL

MorphoSys AG and Xencor Inc. today announced the publication of final results of a Phase 1/2a trial evaluating MOR208 (formerly XmAb5574) in patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic leukemia (CLL/SLL). [More]
Two medical imaging techniques could predict effectiveness of TB drugs

Two medical imaging techniques could predict effectiveness of TB drugs

Two medical imaging techniques, called positron emission tomography (PET) and computed tomography (CT), could be used in combination as a biomarker to predict the effectiveness of antibiotic drug regimens being tested to treat tuberculosis (TB) patients, according to researchers at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. [More]
Study: PET scanning strategy could help predict effectiveness of TB drugs

Study: PET scanning strategy could help predict effectiveness of TB drugs

Sophisticated lung imaging can show whether or not a treatment drug is able to clear tuberculosis (TB) lung infection in human and macaque studies, according to researchers at the University of Pittsburgh School of Medicine and their international collaborators. [More]
SurgiQuest receives Most Promising Life Sciences Company of the Year award

SurgiQuest receives Most Promising Life Sciences Company of the Year award

SurgiQuest was awarded "Most Promising Life Sciences Company of the Year" due to its potential for growth, success and impact on the Life Sciences market in Connecticut. The company's flagship product, the AirSeal System, improves patient outcomes, enhances perioperative efficiency, reduces costs and increases hospital profitability. [More]
Fiagon's ENT Extended Instrument Set receives FDA approval

Fiagon's ENT Extended Instrument Set receives FDA approval

Fiagon AG medical technologies announced today that it received U.S. Food and Drug Administration 510(k) clearance for its ear, nose and throat (ENT) Extended Instrument Set. The clearance includes the company's tip-navigated GuideWire, PointerShell instrument adaptor and FlexTube navigated suction and irrigation. [More]

Cytation™ 5 Cell Imaging Multi-Mode Reader to be introduced by BioTek at ASCB 2014

Join BioTek Instruments as they introduce the Cytation™ 5 Cell Imaging Multi-Mode Reader at the ASCB 2014 Conference and Exhibition to be held December 6-10 in Philadelphia, Pennsylvania. BioTek’s “Think Possible” philosophy is reflected in their microplate-based imaging, detection, liquid handling and automation solutions and the company will showcase their newest innovations at Booth #349. [More]
U-M startup company Imbio gets FDA approval to market Lung Density Analysis for COPD

U-M startup company Imbio gets FDA approval to market Lung Density Analysis for COPD

A technology that started in a University of Michigan Medical School lab may soon help lung disease patients around the world breathe a little easier, by helping their doctors make a clearer diagnosis and more individualized treatment plan. [More]
Diabetic patients with mild coronary artery disease face increased risk for heart attack

Diabetic patients with mild coronary artery disease face increased risk for heart attack

According to a new long-term study, diabetic patients with even mild coronary artery disease face the same relative risk for a heart attack or other major adverse heart events as diabetics with serious single-vessel obstructive disease. [More]
Bayer unveils enhanced version of Radimetrics Enterprise Platform at RSNA 2014

Bayer unveils enhanced version of Radimetrics Enterprise Platform at RSNA 2014

Bayer today unveiled version 2.5 of its Radimetrics Enterprise Platform at the 2014 Radiological Society of North America Scientific Assembly and Annual Meeting. The enhanced version has new features that can help radiologists and hospital administrators meet new 2015 U.S. Joint Commission Diagnostic Imaging Standards, providing information to help optimize radiation dose management and contrast dose analytics to advance image quality and patient care. [More]
Philips introduces new lung screening solution at RSNA 2014

Philips introduces new lung screening solution at RSNA 2014

Royal Philips today introduced a new lung screening solution designed to offer health care providers a faster and more definitive pathway to lung cancer detection and treatment. Making its debut at the 2014 Radiological Society of North America Annual Meeting in Chicago this week, this total solution is comprised of products and services that enable health care providers to implement and manage a comprehensive computed tomography (CT) lung screening program which tracks and guides patients across the health continuum. [More]
IMRIS successfully completes human factors study for SYMBIS Surgical System

IMRIS successfully completes human factors study for SYMBIS Surgical System

IMRIS Inc. today announced that the Company has successfully completed the human factors study for the SYMBIS Surgical System – the comprehensive validation used to support the product's 510(k) submission to the U.S. Food and Drug Administration on November 26. [More]
3-D printed models assist in face transplantation procedures

3-D printed models assist in face transplantation procedures

Researchers are using computed tomography (CT) and 3-D printing technology to recreate life-size models of patients' heads to assist in face transplantation surgery, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA). [More]
PET/CT may improve differentiation of PTSD from MTBI

PET/CT may improve differentiation of PTSD from MTBI

Hybrid imaging with positron emission tomography and computed tomography (PET/CT) in the pituitary region of the brain is a promising tool for differentiating military veterans with post-traumatic stress disorder (PTSD) from those with mild traumatic brain injury (MTBI), according to a new study presented at the annual meeting of the Radiological Society of North America (RSNA). [More]